(Q35865876)

10 August 2017

1 reference

title

Examining the cost-effectiveness of cancer screening promotion (English)

1 reference

10 August 2017

4

Peter A Briss

1 reference

10 August 2017

M Robyn Andersen

1

1 reference

10 August 2017

Nicole Urban

series ordinal

2

1 reference

10 August 2017

Scott Ramsey

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

101

1 reference

10 August 2017

issue

5 Suppl

1 reference

10 August 2017

page(s)

1229-1238

1 reference

Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

Screening for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

Adverse psychologic consequences of positive cytologic cervical screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

Psychological and behavioral implications of abnormal mammograms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

Interventions that increase use of adult immunization and cancer screening services: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

Cost-Effectiveness of Cervical Cancer Screening: Comparison of Screening Policies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

The cost-effectiveness of lifesaving interventions in Sweden

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Evaluating the cost-effectiveness of clinical and public health measures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Methods for systematic reviews of economic evaluations for the Guide to Community Preventive Services. Task Force on Community Preventive Services

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Demographic predictors of mammography and Pap smear screening in US women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

The use of mammography by survivors of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Screening mammography beginning at age 40 years: a reappraisal of cost-effectiveness

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

The cost-effectiveness of mammographic screening strategies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Randomised study of screening for colorectal cancer with faecal-occult-blood test

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Cost-effectiveness of screening for colorectal cancer in the general population.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Screening for ovarian cancer: a pilot randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Multimodal approach to screening for ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

The cost-effectiveness of cervical cancer screening for low-income elderly women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

The economics of cancer prevention and detection: getting more for less

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Cervical-cancer screening: attendance and cost-effectiveness

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Incidence of and treatment for ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Intraductal carcinoma of the breast: Follow-up after biopsy only

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Prostate cancer intervention. Involving the patient in early detection and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

A quantitative analysis of the costs and benefits of prostate cancer screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Ten-year risk of false positive screening mammograms and clinical breast examinations.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

The impact of abnormal mammograms on psychosocial outcomes and subsequent screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Psychological impact of screening for familial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Enthusiasm for cancer screening in the United States.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Breast cancer screening for elderly women with and without comorbid conditions. A decision analysis model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Lessons learned from community-based cancer screening intervention research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Interventions for patients, providers, and health care organizations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Testing reminder and motivational telephone calls to increase screening mammography: a randomized study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Why women resist screening mammography: patient-related barriers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Cost-effectiveness of interventions to promote cervical screening in general practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Promoting mammography: results of a randomized trial of telephone counseling and a medical practice intervention.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Effectiveness, costs, and cost-effectiveness of recruitment strategies for a mammographic screening program to detect breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Cost-effectiveness comparison of five interventions to increase mammography screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Evaluation of a phone intervention to promote mammography in a managed care plan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Promoting mammography use through progressive interventions: is it effective?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Costs and cost-effectiveness of a clinical intervention to increase mammography utilization in an inner city public health hospital

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Can tailored interventions increase mammography use among HMO women?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

The effectiveness of mammography promotion by volunteers in rural communities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Psychological side effects of breast cancer screening.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20511

7 January 2021

Identifiers

DOI

10.1002/CNCR.20511

1 reference

10 August 2017

1 reference